Curriculum Vitae Name
Johan Antonie den Boer, M.D., Ph.D.
Personal data Date of Birth: Place of Birth: Citizenship: Marital Status:
June, 27, 1953 Meerkerk, The Netherlands Dutch Married to Inge Benders; three children
Education
State High School Gouda and Gorinchem, The Netherlands. State University Utrecht, M.D. degree in 1982 Specialization in Psychiatry University of Amsterdam and Utrecht
Professional experience
Resident in psychiatry at the University Hospital Academic Medical Center of Amsterdam and the University of Utrecht. Registered as a psychiatrist (1986). Appointed as neuropsychiatrist at the Department of Psychiatry of the University Hospital Utrecht (1987). Ph.D. thesis on “Serotonergic mechanisms in anxiety disorders; an inquiry into serotonin function in panic disorder” (1988). Appointed as Associate Professor in Clinical and Biological Psychiatry at the Department of Psychiatry of the University Hospital Utrecht (1989). Since June 1996: Professor of Biological Psychiatry at the Academic Hospital Groningen.
Awards
Scientific Award from the Dutch Society of Psychiatry: the “Ramaer medaille (1989). Eli Lilly CNS Award for research into the biological determinants of anxiety disorders (1996).
Teaching
Regular courses to medical biologists about neurobiology. Education of medical students: training in psychopathology and psychometric measurements. Training of residents in psychiatry in Neuropharmacology and applied psychopharmacology. Postgraduate courses for general practitioners and clinical psychiatrists.
Editorial Work
Member of the Editorial Board of the Journal of Serotonin Research, CNS Drugs, the International Journal of Psychiatry & Clinical Practice and Neuropraxis. Editor-in-chief of the Wiley Series on ‘Clinical and Neurobiological Advances in Psychiatry’ of which the first five volumes have been published. Editor of the ‘Handbook of Depression and Anxiety’ (Marcel Dekker Inc., New York, 1994, revised edition 2003) and ‘Clinical Management of anxiety’ (Marcel Dekker Inc., New York, 1996). First Editor (together with Dr. G.J. ter Horst and Dr. M. George) of: New Developments in Psychopharmacology, Synthesis, in press.
Membership scientific societies:
Distinguished Fellow of the International Society of Affective Disorders (ISAD). President of the Interdisciplinary Society of Biological psychiatry from 1992-1997. Dutch ‘Vereniging of Psychiatry’ (Society of Psychiatry). Section of ‘Psychiatry and Philosophy’ of the Dutch Society of Psychiatry. Association of European Psychiatrists. Member of the European College for Neuropsychopharmacology (ECNP). Member of the Collegium Internationale Neuropsychopharmacologicum CINP).
List of publications 1981 Den Boer, J.A.: Enige gedachten over anthropologische psychiatrie. Nederlands Tijdschrift voor Psychiatrie, 11, 700-713, 1981. 1985 Westenberg, H.G.M., J.A. den Boer and W.M.A. Verhoeven: Recent developments in diagnostic and pharmacologic issues of anxiety disorders. In: Proceedings Symposium "The Borderline between Anxiety and Depression", p. 5-12, 1985. 1986 Den Boer, J.A., W.M.A. Verhoeven and H.G.M. Westenberg: Remoxipride in schizophrenia; a preliminary report. Acta Psychiatrica Scandinavica, 74, 409-414, 1986. 1987 Den Boer, J.A., H.G.M. Westenberg, W.D.J. Kamerbeek, W.M.A. Verhoeven and R.S. Kahn: Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. International Clinical Psychopharmacology, 2, 21-32, 1987. Den Boer, J.A.: Psychoanalyse tussen interpretatie en empirie. Tijdschrift voor Psychiatrie, 404-416, 1987. Westenberg, H.G.M. en J.A. den Boer: Psychofarmacologie van angststoornissen. COBO-Bulletin, 1, 8-15, 1987. Den Boer, J.A., H.G.M. Westenberg and W.M.A. Verhoeven: Negative symptoms in schizophrenia: A review of diagnostic, pathophysiological and therapeutic aspects. New Trends in Clinical and Experimental Psychiatry, 3 (2), 109-145, 1987. Den Boer, J.A. en W.M.A. Verhoeven: Diagnostische en therapeutische aspecten van negatieve symptomen binnen de groep der schizofrene psychosen. COBO-Bulletin, 2, 45-50, 1987. Den Boer, J.A., W.M.A. Verhoeven and H.G.M. Westenberg: Remoxipride, a novel atypical neuroleptic, in the treatment of schizophrenia. Psychopharmacology Bulletin, 23 (1), 206-209, 1987. Westenberg, H.G.M., J.A. den Boer, and R.S. Kahn: Psychopharmacology of anxiety disorders: On the role of serotonin in the treatment of anxiety states and phobic disorders. Psychopharmacology Bulletin, 23 (1), 145-149, 1987. Den Boer, J.A., W.M.A. Verhoeven en H.G.M. Westenberg: Conceptuele en methodologische problemen rondom het thema negatieve symptomen. Tijdschrift voor Psychiatrie, 9, 550-561, 1987. Den Boer, J.A., H.G.M. Westenberg, W.M.A. Verhoeven: Pathofysiologische en therapeutische aspecten van negatieve symptomen. Tijdschrift voor Psychiatrie, 10, 638-653, 1987. Den Boer, J.A. and H.G.M. Westenberg: Effect of a serotonin and noradrenaline uptake inhibitor in panic disorders; a double-blind comparative study with fluvoxamine and maprotiline. International Journal of Clinical Psychopharmacology, 3, 59-74, 1988. 1988 Den Boer, J.A., H.G.M. Westenberg and W.M.A. Verhoeven: Atypical neuroleptics in the treatment of schizophrenic psychoses. New Trends in Clinical and Experimental Psychiatry, IV (1), 47-55, 1988.
Den Boer, J.A. and H.G.M. Westenberg: Evidence for a serotonergic dysfunction in Panic Disorder. In: Proceedings of the Symposium "Depression, Anxiety and Agression", 91-102, 1988. Westenberg, H.G.M., J.A. den Boer and W.M.A. Verhoeven: Biological aspects of anxiety disorders; a concise review. European Journal of Psychiatry, 2(4), 197-210. 1988. 1989 Westenberg, H.G.M. and J.A. Den Boer: Serotonin influencing drugs in the treatment of panic disorder. Psychopathology, 22, 68-77, 1989. Den Boer JA, Westenberg HGM, Klompmakers AA, van Lint EM. Behavioral biochemical and neuroendocrine concomittants of lactate-induced panic anxiety. Biological Psychiatry 26, 612-622, 1989. Den Boer, J.A.: Biologische determinanten van persoonlijkheidsstoornissen. Proceedings Symposium Persoonlijkheidsstoornissen, Ermelo, 59-67, juni 1989. Den Boer, J.A., H.G.M. Westenberg et W.M.A. Verhoeven: Aspects physiopathologiques et therapeutiques des symptomes negatifs dans des psychoses schizophreniques. L'Enc phale, XV, 273282, 1989. Den Boer, J.A.: Serotonergic mechanisms in anxiety disorders. Pharmaceutisch Weekblad Scientific Edition, 11, 3, 103-104, 1989. Den Boer, J.A.: Serotonerg neuronale systemen en angststoornissen. Soma & Psyche, 2, 7-12, 1989. Westenberg, H.G.M. and J.A. den Boer: Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder. Psychopharmacology Bulletin, 25, 1, 119-123, 1989. Den Boer, J.A. and H.G.M. Westenberg: Behavioral, biochemical and neuroendocrine concomitants of lactate induced panic anxiety. Biological Psychiatry, 26, 612-622, 1989. Westenberg, H.G.M. and J.A. den Boer: Serotonin function in panic disorder; effects of L-5-hydroxytryptophan in patients and controls. Psychopharmacology, 98, 283-285, 1989. Den Boer, J.A., H.G.M. Westenberg, B. Mastenbroek and J.M. van Ree: ACTH4-9 (Org. 2766) in panic disorder: A preliminary study. Psychopharmacology Bulletin, 1989, 25(2), 204-208, 1989. Den Boer, J.A.: Diagnostische aspecten van angststoornissen. Soma & Psyche, 1, 17-20, 1989. Den Boer, J.A. en H.G.M. Westenberg: Over de rol van serotonine (5-HT) bij angststoornissen. Farmaceutisch Weekblad, 124, 755-760, 1989. Den Boer, J.A.: International Symposium on "Serotonin: from cellbiology to pharmacology and therapeutics". Tijdschrift voor Therapie, Geneesmiddelen en Onderzoek, 14, 265-266, 1989. 1990 Den Boer, J.A. en W.M.A. Verhoeven: Atypische neuroleptica bij de behandeling van schizofrene psychosen. COBO-Bulletin, (1), 10-17, 1990. Den Boer, J.A. and H.G.M. Westenberg: Behavioral, neuroendocrine and biochemical concomitants of 5-HTP administration in panic disorder. Psychiatry Research, 31, 267-278, 1990. Den Boer, J.A. and H.G.M. Westenberg: Serotonin function in panic disorder: a double blind study of fluvoxamine and ritanserin. Psychopharmacology, 102: 85-94, 1990.
Den Boer, J.A., H.G.M. Westenberg and W.M.A. Verhoeven: Biological aspects of panic anxiety. In: R. de la Fuente (ed): Psychiatric Annals: 20;9: 494-502, 1990. Den Boer, J.A. and H.G.M. Westenberg: Psychofarmacologie van angststoornissen. COBO-Bulletin 16.1., 7-9, 1990. Den Boer, J.A., D.P. Ravelli, J. Huisman, J. Ohrvik, W.M.A. Verhoeven and H.G.M. Westenberg: A double blind comparative study of remoxipride and haloperidol in acute schizophrenia. Acta Psychiatrica Scandinavica, 358, 82, 108-110, 1990. Den Boer, J.A. and H.G.M. Westenberg: Atypical neuroleptics in the treatment of acute schizophrenia: a double blind comparative study of remoxipride and haloperidol. Psychopharmacology Bulletin, 26,1; 99-107, 1990. J.A. den Boer, W.M.A. Verhoeven: Neuroleptiques atypiques: Revue des donn s cliniques existantes. L'Enc phale, XVI, 439-444, 1990 Den Boer, J.A., D.P. Ravelli, J. Huisman, J. Ohrvik, W.M.A. Verhoeven and H.G.M. Westenberg: A double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients. Psychopharmacology, 102: 76-84, 1990. Den Boer, J.A., D.P. Ravelli, J. Huisman, W.M.A. Verhoeven en H.G.M. Westenberg: Een vergelijkende studie tussen het atypische neurolepticum remoxipride en haloperidol bij schizofrene pati nten. COBO-Bulletin, 90; 1:31-36, 1990. Westenberg, H.G.M., J.A. den Boer: Guidelines to ensure antipanic drugs are effective. Proceeding of the 37th C.I.N.P. Congress, Tokyo, 1990. 1991 Den Boer, J.A.: Diagnostische en farmacotherapeutische aspecten van obsessief compulsieve stoornis. Proceedings Symposium: "Het heilige moeten: van plicht tot dwang (OCD)", PAAZ, De Wezenlanden, Zwolle, maart 1991. Den Boer, J.A., H.G.M. Westenberg summary of: Behavioral neuroendocrine and biochemical effects of 5-Hydroxytryptophan Administration in Panic Disorder. in: Focus on Anxiety, 11:19-22, 1991. Volkerts, E.R., Van Laar, M.W., Van Willigenburg A.P.P., Bekker, E.J., Plomp, T.A., Den Boer, J.A., Maes, R.A.A. : A double-blind study of the therapeutic effects and the effects on actual driving performance of chronically administered Buspirone and Diazepam in outpatients with generalized Anxiety Disorder. febr.'91, Onderzoeksverslag NIDDR. Den Boer, J.A. Pharmacotherapeutische overwegingen over podiumangst. The Practitioner, 1991, 16, 1079-1081. Den Boer, J.A. Angst voert de boventoon, Editorial The practitioner 1991, 16; 1051-1052. Den Boer, J.A., H.G.M. Westenberg : Do panic attacks reflect an abnormality in serotonin receptor subtypes? Human Psychopharmacology, (6) S25-30, 1991. 1992 Den Boer, J.A., H.G.M. Westenberg: Diagnostische aspecten van angststoornissen. Diagnose Informatie en Medische Statistiek, 1992, 13, 7-9.
Westenberg, H.G.M., J.A. den Boer: Farmacotherapie van angststoornissen. Diagnose Informatie en Medische Statistiek, 1992, 13, 10-14. Den Boer, J.A., H.G.M. Westenberg, J.W. Louwerens, C.F. Slooff: Over de klinische betekenis van atypische neuroleptica. Acta neuropsychiatrica, 1992; 3, 55-60. Van Megen, H.J.G.M., J.A. den Boer, H.G.M. Westenberg: Neuropeptiden en angststoornissen. Acta Neuropsychiatrica, 1992, 2, 25-31. Van Vliet, I.M., J.A. den Boer, H.G.M. Westenberg: Psychopharmacology of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-inhibitor. European Neuropsychopharmacology; 2, 21-29, 1992. Den Boer, J.A., H.J.G.M. van Megen, H.G.M. Westenberg: Subtypes of depression and serotonin function. Biological Psychiatry, International Congress Series; Racagni, G., Brunello, N., Fukuda T. (Eds), 1992, vol.I, 315-317. Westenberg, H.G.M., J.A. Den Boer. Panic Disorder: from symptoms to neurobiological substrate. Editorial in: The International Monitor, 1992; 3, 31-33. Den Boer, J.A., H.J.G.M. van Megen, H.G.M. Westenberg, J. Haigh, M. Traub. On the role of CCK and CCK-B receptors in the pathophysiology of panic disorder. Proceedings ICB Congress, London 1992. Den Boer, J.A., H.G.M. Westenberg. The MSH/ACTH analog ORG 2766 in anxiety disorders. Peptides 13, 109-112, 1992. Bosschaert MAR, JA Den Boer. Het slaapapneu syndroom in de psychiatrie. Tijdschrift voor psychiatrie (8):525-537, 1992. Den Boer JA, HGM Westenberg. Oxytocin in obsessive compulsive disorder. Peptides,(13) 10831085, 1992. Den Boer, J.A, H.G.M. Westenberg. De klinisch psychiatrische betekenis van 5-HT receptor subtypen. COBO Bulletin 3:11-19, 1992. 1993 Van Megen, H.J.G.M., H.G.M. Westenberg, J.A. Den Boer. Aanwijzingen voor een verhoogde gevoeligheid voor pentagstrine bij patienten lijdende aan paniekstoornis. Acta Neuropsychiatrica, 5:23-28, 1993. De Leeuw, A, J.A. Den Boer en H.G.M. Westenberg. Een decennium biologisch psychiatrisch onderzoek bij obsessief compulsieve stoornis I; behandelstudies. Acta Neuropsychiatrica, 5:1-7, 1993. De Leeuw, A., J.A. Den Boer, H.G.M. Westenberg. Een decennium biologisch psychiatrisch onderzoek bij obsessief compulsieve stoornis; challenge- en neuroanatomische studies. Acta Neuropsychiatrica, 5: 7-15, 1993. Den Boer JA, AS de Leeuw, HGM Westenberg Serotonin function in obsessive compulsive disorder; a challenge study with 5-HTP. Proceedings of the first international obsessive compulsive disorder conference. March 12-12, p. 47, 1993. Westenberg HGM, de Leeuw AS, Den Boer JA. Serotonin reuptake blockers in obsessive compulsive disorder: a controlled trial with fluvoxamine. Proceedings of the first international obsessive compulsive disorder conference. Capri, March 12-14, p.47, 1993.
Den Boer JA, AS de Leeuw, HGM Westenberg Pentagastrin challenge in obsessive compulsive disorder: a pharmacological probe for the dissociatioon of anxiety and obsessive compulsive symptoms? Proceeding of the first international obsessive compulsive conference. may 12-13, 1993, 137-138. Van Vliet IM, HGM Westenberg, JA Den Boer. MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study. Psychopharmacology, 1993, 112, 483-489. Van Dalen R, JA Den Boer. Puberteit of erfelijkheid? Acta Neuropsychatrica, 5;19-22, 1993, Verhoeven WMA, JA Den Boer Psychopharmacological treatment strategies in schizophrenia. State of the art in clinical psychiatry,vol 1, nr 3, 4-16, 1993. Den Boer JA, HGM Westenberg, IM van Vliet. Recente ontwikkelingen in de psychofarmacologie van angststoornissen. Modern Medicine, 1993, 11; 782-787. Den Boer JA, HGM Westenberg. Remoxipride, een nieuw atypisch antipsychoticum. Tijdschrift voor Geneesmiddelenonderzoek TGO 18;36-41, 1993. Den Boer JA, IM van Vliet, HGM Westenberg. Recente ontwikkelingen in de psychofarmacologie van sociale fobie. Acta Neuropsychiatrica, 5, 76-82, 1993. Westenberg, HGM, JA Den Boer, HJGM van Megen. The role of serotonin and cholecystokinin in panic disorder. European NeuroPsychopharmacology, 1993, 3 (3), 258-259. Den Boer JA, HGM Westenberg. Kritische kanttekeningen bij de locus coeruleus hypothese van paniekstoornis. Acta Neuropsychiatrica, 1993, 5, 48-54. Den Boer JA, HGM Westenberg, HJGM van Megen. The significance of biological mechanisms in the pathophysiology of panic disorder. In: State of the art in clinical psychiatry, 1993, (6):4-14. Westenberg HGM, JA Den Boer. New findings in the treatment of panic disorder. Pharmacopsychiatry, 1993 (26):30-33. Den Boer JA, IM van Vliet, HGM Westenberg. Pharmacological treatment of social phobia; recent developments. In: European Neuropsychopharmacology 1993,3 (3) 190-192. 1994 Bradwejn J, Koszycki D, Coutoux du Tertre, A., H van Megen, JA Den Boer, H Westenberg, L Anable. The panicogenic effects of CCK-tetrapeptide are antagonized by L-365,260, a central CCK receptor antagonist in patients with panic disorder. Archives of General Psychiatry, 1994;51: 486-493. Den Boer JA, IM van Vliet, HGM Westenberg. Recent advances in the psychopharmacology of social phobia. Progress in Neuropsychopharmacology and Biological Psychiatry, 1994;18; 625-645. Van Vliet, IM, JA Den Boer, HGM Westenberg. Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine. Psychopharmacology 1994, 115:128-134. Van Megen HJGM, JA Den Boer, HGM Westenberg. On the significance of cholecystokinin receptors in panic disorder. Progress in Neuropsychopharmacology and Biological Psychiatry, 18: 1235-1246, 1994. Den Boer JA, HJGM van Megen, HGM Westenberg. Significance of CCK-B receptors in the neurobiology of panic disorder. European Neuropsychopharmacology, 1994; 4(3):273-275.
Westenberg HGM, JA Den Boer. Psychopharmacological tests in social phobia. European Neuropsychopharmacology 1994, Abstract Book: 2-3. Van Megen HJGM, Westenberg HGM, Den Boer JA, Haigh JR, Traub M. Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients. Psychopharmacology, 1994; 114: 449-455. 1995 Den Boer, JA, IM van Vliet, HGM Westenberg. Recent developments in the psychopharmacology of social phobia. European Archives of Psychiatry and Clinical Neuroscience, 1995, 244: 309-316. Slaap BR, van Vliet, Westenberg HGM, Den Boer JA. Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report). Journal of Affective Disorders 1995; 33:31-38. Den Boer, JA. Polemiek met Dr. van den Burg n.a.v. artikel: De werkzaamheid van antidepressiva. Maandblad Geestelijke Volksgezondheid, 3; 285-288, 1995. Den Boer JA, Westenberg HGM, de Leeuw, AS, van Vliet IM. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine. International Clinical Psychopharmacology, 1995, 9, Suppl 4: 47-52. Den Boer JA, Van Megen HJGM, Fleischhacker WW, Louwerens JW, Slaap BR, Westenberg HGM, Burrows GD, Srivastava ON. Differential effects on the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia. Psychopharmacology 1995; 121: 317-322. Den Boer JA, A History of Biological Psychiatry in The Netherlands. Acta Neuropsychiatrica, 1995, VII(3), S2-S10. Den Boer JA, Risperidon bij de behandeling van psychosen, een overzicht. Acta Neuropsychiatrica, 7: 84-94, 1995. Den Boer JA, HJGM van Megen, W. Fleischakker, JW Louwerens, BR Slaap, HGM Westenberg, GD Burrows, ON Srivastava. Differential effects of the D1-DA antagonist SCH 39166 on positive and negative symptoms of schizophrenia. Psychopharmacology, 121: 317-322, 1995. Den Boer JA, HGM Westenberg. Serotonergic compounds in panic disorder, obsessive compulsive disorder and anxious depression; a concise review Human Psychopharmacology, 10: S173-183, 1995. 1996 Slaap BR, IM van Vliet, HGM Westenberg, JA Den Boer. Responders and non-responders to drug treatment in social phobia: differences at baseline and prediction of response. Journal of Affective Disorders 39, 13-19, 1996. Van Megen HJGM, HGM Westenberg, JA Den Boer, RS Kahn. The panic-inducing properties of the cholecystokinin tetrapeptide CCK-4 in patients with panic disorder. European Neuropsychopharmacology 6, 187-194, 1996. Slaap BR, JA Den Boer, HGM Westenberg. De voorspelling van non-respons op farmacotherapie bij paniekstoornis; een overzicht van korte termijn voorspellers. Tijdschrift voor Psychiatrie, 38(5), 371382, 1996. De Leeuw AS, JA Den Boer, BR Slaap, HGM Westenberg. Pentagastrin has panic-inducing properties in obsessive compulsive disorder. Psychopharmacology 126: 339-344, 1996.
Montgomery SA, D Bakish, R Buller, Y Lecrubier, JP Lepine, M Mauri, N Sartorius, A Cameron, J Costa e Silva, JA Den Boer, C Freeman, L. von Knorrig, H Loo, D Nutt, R. Rosenberg. ECNP position paper on social phobia. European Neuropsychopharmacology, 6:77-83, 1996. Van Vliet IM, BR Slaap, HGM Westenberg, JA Den Boer. Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder. European Neuropsychopharmacology 6, 103-110, 1996. Slaap BR, van Vliet IM, Westenberg HGM, Den Boer JA. MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients. A preliminary report. Psychopharmacology 127: 353-358, 1996. Slaap BR, JA Den Boer, HGM Westenberg. De voorspelling van non-response op farmacotherapie; een overzicht van lange termijn voorspellers. Tijdschrift voor Psychiatrie 38(11), 822-832, 1996 Van Vliet IM, Den Boer JA, Westenberg HGM, Slaap BR. A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder. Journal of Clinical Psychopharmacology 16: 299-306, 1996. Van Megen HJGM, Westenberg HGM, Den Boer JA, Kahn RS. Review. Cholecystokinin in anxiety. European Neuropsychopharmacology 6: 263-280, 1996. Van Megen HJGM, Westenberg HGM, Den Boer JA. De rol van de cholecystokinine-B- receptor bij paniekstoornissen. Acta Neuropsychiatrica 8, 99-101, 1996. Slaap BR, Van Vliet IM, Westenberg HGM, Den Boer JA. Reactiepredictie bij angststoornissen. Acta Neuropsychiatrica 8: 102-104, 1996. Van Vliet IM, Westenberg HGM, Den Boer JA. Effects of the 5-HT1A receptor agonist flesinoxan in panic disorder. Psychopharmacology,127: 174-180, 1996. Van Megen HJGM, HGM Westenberg, JA Den Boer. Effects of the cholecystokinin-B receptor antagonist L-365,260 on lactate-induced panic attacks in panic disorder patients. Biological Psychiatry 1996; 40:804-806. 1997 Van Megen HJGM, Westenberg HGM, Den Boer JA, Slaap BR, Scheepmakers A. Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks. Psychopharmacology 129: 357-364, 1997. Van Megen HJGM, Westenberg HGM, Den Boer JA, Slaap BR, Van Es-Radhakishun F, Pande, AC. The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients. Psychopharmacology 129: 243-248, 1997. Van Vliet IM, Den Boer JA, Westenberg HGM, Ho Pian KL. Clinical effects of Buspirone in social phobia: a double-blind placebo-controlled study. Journal of Clinical Psychiatry 58: 164-168, 1997. Den Boer JA, Van Vliet IM, Westenberg HGM, Slaap BR, Van Megen HJGM. Farmacotherapie bij patienten met angststoornissen. Pharmaceutisch Weekblad 132(18), 578-589, 1997. Den Boer JA. A farewell to Herman van Praag from the board of the Interdisciplinary Society of Biological Psychiatry. Acta Neuropsychiatrica 9(2), 11-12, 1997. Den Boer JA. Defining panic - a diganostic dilemma. Human Psychopharmacology 1997; 12:S3-S6.
Van Vliet IM, Westenberg HGM, Slaap BR, Den Boer JA, Ho Pian KL. Anxiogenic effects of pentagastrin in patients with social phobia and healthy controls. Biological Psychiatry 1997; 42: 7678. Den Boer JA. Psychopharmacology of comorbid obsessive-compulsive disorder and depression. Journal of Clinical Psychiatry 1997; 58 (suppl 8): 17-19. Ballenger JC, Den Boer JA. Current controversy: What features define panic disorder? Human Psychopharmacology 1997; 12: S1-S2. Rouillon F, Den Boer JA. Case history presented by F Rouillon, response from JA den Boer. Human Psychopharmacology 1997; 12: S35-S36. Nutt DJ, Den Boer JA. Case history presented bu DJ Nutt, response from JA den Boer. Human Psychopharmacology 1997; 12: S39-S40. Den Boer JA. Social Phobia: epidemiology, recognition and treatment. British Medical Journal 1997; 315: 796-800. Het buigzame brein. Over hersenen en geest, neuraal darwinisme en psychiatrie. Acta Neuropsychiatrica 1997; 9: 97-106. Steen A, JA Den Boer, A double blind six months comparative study of milnacipran and clomipramine in major depressive disorder. Int Clin Psychopharmacology 1997; 12: 269-281 1998 Den Boer JA, Slaap BR. Review of current treatment in panic disorder. Int Clin Psychopharmacology 1998: 13; S25-S30. Den Boer JA. Pharmacotherapy of panic disorder: differential efficacy from a clinical viewpoint. J Clin Psychiatry 1998: 59; 30-36. Ho pian KL, Westenberg HGM, Den Boer JA, De Bruin WI, Van Rijk PP. Effects of metachlorophenylpiperazine on cerebral blood flow in obsessive-compulsive disorder and controls. Biol Psychiatry 1998; 44: 367-370. Steen A, JA Den Boer, A double blind six months comparative study of milnacipran and clomipramine in major depressive disorder. Intern Wetenschappelijk Magazine 1998: 9e jaargang nr. 3 (36); 17-41 (Psychiatrisch centrum Zon & Schild). Klaassen T, Ho-Pian KL, Westenberg HGM, Den Boer JA, Van Praag HM Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine. Psychiatry Res, 1998, 79, 207-12. Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Baldwin DS, Den Boer JA, Kasper S, Shear MK. Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 1998, 59, 47-54. Ho Pian KL, Westenberg HGM, Van Megen HJGM, Den Boer JA. Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder and controls. Psychopharmacology, 1998, 140, 365-370. 1999 Den Boer JA. The choice of treatment in severe depression: the severe depression meta-analysis. Primary Care Psychiatry, 1999, 5, S21-S24.
Timmerman W, Heijmen M, Westerink BHC, Bruggeman R, Den Boer JA. Effects of acute and chronic administration of olanzapine in comparison to clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons in the rat brain.Psychopharmacology, 1999, 144, 286294. Den Boer JA, Baldwin D, Bobes J, Katschnig H, Westenber H, Wittchen H-U. Social anxiety disorder - our current understanding. Int J Psych Clin Pract, 1999, 3, S3-S13. Den Boer JA, Dunner DL. Physician attitudes concerning diagnosis and treatment of social anxiety disorder in Europe and North America. Int J Psych Clin Pract, 1999, 3, S13-S19. Crawford TJ, Broerse A, Den Boer JA. Dopamine and impairment at the executive level. Behavioural and Brain Sciences, 1999, 22, 678-679. 2000 Koorengevel KM, Beersma DGM, Gordijn MCM, Den Boer JA, Van den Hoofdakker RH. Body temperature and mood variations during forced desynchronization in winter depression: a preliminary report. Biol Psychiatry, 2000, 47, 355-358. Rinne Th, Westenberg HGM, Den Boer JA, van den Brink W. Serotonergic blunting to metachlorophenylpiperzine (m-CPP) highly correlates with sustained childhood abuse in impulsive and auto-aggressive female borderline patients. Biol Psychiatry, 2000, 47, 548-556. Den Boer JA, Vahlne JO, Post P, Heck A, Daubenton F, Olbrich R. Ritanserin as add-on medication to neuroleptic therapy, for patients with chronic or subchronic schizophrenia. Human Psychopharmacology Clin. Exp. , 2000, 15, 179-189. Den Boer JA, Bosker FJ, Slaap BR. Serotonergic drugs in the treatment of depressive and axiety disorders. Human Psychopharmacol Clin Exp., 2000, 15, 315-336. Boshuisen ML, Den Boer JA. Zolmitriptan (a 5-HT1B/1A receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder. Psychopharmacology, 2000, 152: 74-79. Den Boer JA, Van Vliet IM. Social phobia: diagnostic, neurobiological and treatment perspectives. Primary Psychiatry, 2000, 7 (7): 40-47. Cremers TIFH, De Boer P, Liao Y, Bosker FJ, Den Boer JA, Westerink BHC, Wikström HV. Augmentation with a 5-HT1A antagonist, but not a 5-HT1B antagonist critically depends on the dose of citalopram. A pharmacodynamic and pharmacokinetic study. European Journal of Pharmacology, 2000, 397: 63-74. Cremers TIFH, Spoelstra EN, De Boer P, Bosker FJ, Mørk A, Den Boer JA, Westerink BHC, Wikström HV. Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram. European Journal of Pharmacology, 2000, 397, 351-357. Den Boer JA. Social anxiety disorder/social phobia: epidemiology, diagnosis, neurobiology and treatment. Comprehensive Psychiatry, 2000, 41, 405-415. Brunello N, Den Boer JA, Judd LL, Kasper S, Kelsey SE, Lader M, Lecrubier Y, Lepine JP, Lydiard RB, Mendlewicz J, Montgomery SA, Racagni G, Stein MB, Wittchen HU. Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. Journal of Affective Disorders, 2000, 60 (1), 61-74. 2001
Nielen MMA, Den Boer JA. Hersenen en dwang: een integratie van neuroimaging-onderzoek en neuropsychologisch onderzoek bij de obsessieve compulsieve stoornis. Tijdschrift voor Psychiatrie, 2001, 43 (2), 105-113. Bosker FJ, Cremers TIFH, Jongsma ME, Westerink BHC, Wikström HV, Den Boer JA. Acute and chronic effects of citalopram on postsynaptic 5-Hydroxytryptamine1A (5-HT1A) receptor mediated feedback: a microdialysis study in the amygdala. J Neurochemistry, 2001, 76, 1645-1653. Broerse A, Crawford TE, Den Boer JA. Parsing cognition in schizophrenia using saccadic eye movements: A selective overview. Neuropsychologia, 2001, 39, 742-756. Broerse A, Crawford TJ, Den Boer JA. Saccade paradigma’s en cognitie: een overzicht. Nederlands Tijdschrift voor Psychiatrie, 2001, 43, 233-244. Cremers TIFH, Wiersma LJ, Bosker FJ, Den Boer JA, Westerink BHC, Wikström HV. Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism? Society of Biological Psychiatry, 2001, 50: 13-21. Den Boer JA, Van Vliet IM. Fobia social: perspectivas de diagnóstico, neurobiológicas y de tratamiento. Psiquiatría y salud integral, 2001, 1: 35-43. Broerse A, Holthausen EAE, Van den Bosch RJ, Den Boer JA (2001) Does frontal normality exist in schizophrenia? A saccadic eye movement study. Psychiatry Res, 103, 167-178. Slaap BR, Den Boer JA (2001): The prediction of nonresponse to pharmacotherapy in panic disorder. A review. Depression and Anxiety, 14, 112-122. Koorengevel KM, Gordijn MCM, Beersma DGM, Meesters Y, Den Boer JA, Van den Hoofdakker RH, Daan S. Extraocular light therapy in winter depression: a double-blind placebo-controlled study. Biological Psychiatry, 2001, 50, 691-698. Boshuisen ML, Slaap BR, Vester-Blokland ED, Den Boer JA (2001). The effect of mirtazapine in panic disorder, an open label pilot study with a single blind placebo run in period. Int Clin Psychopharmacol, 16, 363-368. 2002 Reinders AATS, Paans AMJ, De Jong BM, Den Boer JA, Willemsen ATM (2002). Iterative versus filtered backprojection reconstruction for statistical parametric mapping of PET activation measurements: a comparative case study. NeuroImage, 15, 175-181. Broerse A, Timmerman W, Westerink BHC, Den Boer JA (2002) Antipsychotics and single cell activity in the rat superior colliculus. Progress in Neuro-Psychopharmacology & Biol Psychiatry, 26, 327-333. Slaap BR, Boshuisen ML, Van Roon, AM, Den Boer, JA. Heart rate variability as predictor of nonresponse to mirtazapine in panic disorder; a preliminary study (2002) International Clinical Psychopharmacology, 17, number 2 March, 69-74. Nielen MMA, De Jong R, Mulder G, Den Boer JA (2002). Decision making performance in obsessive compulsive disorder. Journal of Affective Disorders, 69, 257-260. Boshuisen ML, Ter Horst GJ, Paans AMJ, Reinders AATS, Den Boer JA (2002). rCBF differences between panic disorder patients and control subjects during anticipatory anxiety and rest. Biological Psychiatry, 52, 126-135.
Beersma DGM, Dols LCW, Mersch PPA, Den Boer JA, Van den Hoofdakker RH (2002) Lithium concentrations in plasma of lithium-treated psychiatric patients. Psychiatry Research, 111, (1) 43-44. Koorengevel KM, Beersma DGM, Den Boer JA, van den Hoofdakker RH (2002) A forced desynchrony study of circadian pacemaker characteristics in seasonal affective disorder. Journal of Biological Rhythms, 17, (5) 463-475. Trentani A, Kuipers SD, Ter Horst GJ, Den Boer JA (2002) Selective chronic stress-induced in vivo ERK1/2 hyperphosphorylation in medial prefrontocortical dendrites: implications for stress-related cortical pathology? Eur J Neurosci, 15, (10), 1681-91. Den Boer JA, Evans DL, Lee S, Salin-Pascual R (2002) Unraveling the diagnostic clues of depression and GAD: the primary care challenge. Psychopharmacology Bulletin, 36, (suppl.2), 150-157. Reinders AATS, Willemsen ATM, Georgiadis JR, Hovius M, Paans AMJ, Den Boer JA (2002). Interscan displacement-induced variance in PET activation data Is excluded by a scan-specific attenuation correction. NeuroImage, 17, 1844 – 1853. Broerse A, Crawford TJ, Den Boer JA (2002) Differential effects of olanzapine and risperidone on cognition in schizophrenia? A saccadic eye movement study, The journal of Neuropsychiatry and Clinical Neurosciences, 14, 454-460. 2003 Westenbroek C, Ter Horst GJ, Roos MH, Kuipers SD, Trentani A, Den Boer JA (2003). Genderspecific effects of social housing in rats after chronic mild stress exposure. Progress in NeuroPsychopharmacology & Biological Psychiatry, 27, 21-30. Den Boer JA, Evans DL, Lee S, Salin-Pascual R (2003) Unraveling the diagnostic clues of depression and GAD: the primary care challenge. Mental Fitness, Jan/Feb, Vol. 2, No. 1. Tops M, van der Pompe G, Baas D, Mulder LJM, Den Boer JA, Meijman TF, Korf J (2003). Actue cortisol effects on immediate free recall and recognition of nouns depend on stimulus valence. Psychophysiology, 40, 167-173. Kuipers SD, Trentani A, Den Boer JA, Ter Horst GJ (2003) Molecular correlates of impaired prefrontal plasticity in response to chronic stress. Journal of Neurochemistry, 85, 1312-1323. Nielen MMA, Den Boer JA. Neuropsychological performance of OCD patients before and after treatment with fluoxetine: evidence for persistent cognitive deficits (2003). Psychological Medicine, 33, 917-925.
Books/Book chapters 1988 Verhoeven, W.M.A. and J.A. den Boer: Novel atypical antipsychotic compounds; Recent developments in the treatment of schizophrenia. In: M.E. Wolf and A.D. Mosnaim (Eds.), Tardive Dyskinesia: Biological Mechanisms and Clinical Aspects. American Psychiatric Press Inc., Washington, pp. 245-258, 1988. Westenberg, H.G.M. and J.A. den Boer: Clinical and biochemical effects of selective 5-HT uptake inhibitors in anxiety disorders. In: M. Gastpar (ed.); Selective 5-HT uptake inhibitors: Novel or common place agents? S. Karger AG, Basel, vol. 17, 84-99, 1988. Den Boer, J.A., H.G.M. Westenberg, B. Mastenbroek and H. de Vries: Neurobiological mechanisms in panic disorder; the role of serotonin. In: H.G.M. Westenberg and P.W. Vlottes (Eds.), Developments in Biological Psychiatry, pp. 17-22, 1988. Den Boer, J.A.: Serotonergic mechanisms in anxiety disorders; an inquiry into serotonin function in panic disorder. Thesis, University of Utrecht, 1988. Verhoeven, W.M.A., J.M. van Ree and J.A. den Boer: Neuropeptiden en Schizofrenie. In: Schizofrenie: Moderne ontwikkelingen in onderzoek en behandeling. Van den Bosch, R.J. en Van Meer, R. (eds.); Van Loghum Slaterus, pp. 114-132, 1988. 1991 Den Boer, J.A., H.G.M. Westenberg.: Biologische aspecten van angststoornissen. in: Jaarboek voor psychiatrie en psychotherapie. (C.A.L. Hoogduin e.a. Red), Van Loghum Slaterus, 19-34, 1991. Den Boer, J.A., Westenberg H.G.M., Syllabus: Diagnostiek en biologisch psychiatrische aspecten van angststoornissen I. Cursusboek behorend bij studiedagen Nederlandse Psychiaters, georganiseerd door Afd. Biologische Psychiatrie. Utrecht, 21 en 22 febr. 1991 Den Boer, J.A., H.G.M. Westenberg and W.M.A. Verhoeven: Pathophysiology of anxiety disorders: the Biology of Panic Disorder. In: Seva, A. (Ed.): European Handbook of Psychiatry and Mental Health, Premas Universitarias de Aragon, 715-728, 1991. Westenberg, H.G.M., J.A. den Boer: Treatment of Panic Disorder: Evidence supporting the role of serotonin. in: C. Idzikowski and P.J. Cohen (Eds): Serotonin, Sleep and Mental Disorder, 147-160, Wrightson Biomedical Publishing Ltd, 1991. 1992 Den Boer JA, HGM Westenberg, IM van Vliet. Nieuwe inzichten in de farmacotherapie van angststoornissen. In: MP Springer (ed): Vorderingen in de praktijk, Boerhaave Cie, Leiden, p. 9-20, 1992. 1993 Westenberg HGM, JA Den Boer. Serotonergic basis of panic disorder. In: S. Montgomery (Ed): Psychopharmacology of panic, Oxford University Press, 91-109, 1993. Den Boer JA. Tussen tekst en receptoren; over het impliciete mensbeeld van de biologische psychiatrie. In: (D Bauduin, Red.): De invloed van hedendaagse filosofische stromingen op de theorie en praktijk van de geestelijke gezondheidszorg. Ned. Centrum Geestelijke Volksgezondheid, 73-84, 1993. Den Boer, JA, HGM Westenberg, HJGM van Megen. Biologische aspecten van paniekstoornis. In: Recente inzichten in de ontstaanwijze van paniek en dwang. (Red: R. van Dijck en DJ Veltman), 4757, 1993.
Den Boer, J.A., Westenberg H.G.M. en HJGM van Megen. Syllabus: Diagnostiek en biologisch psychiatrische aspecten van angststoornissen II. Cursusboek behorend bij studiedagen voor Nederlandse Psychiaters, georganiseerd door Afd. Biologische Psychiatrie. Utrecht, 13 en 14 mei 1993. 1994 Den Boer, J.A., Sitsen J.M.A. (Eds.) Handbook of Depression and Anxiety: a Biological Approach. Marcel Dekker Inc., New York, 1994. Westenberg HGM, JA Den Boer. Serotonin in anxiety and related disorders. In : Vanhoutte, PM, Paoletti R, PR Saxena (Eds): Serotonin: From Cell Biology to Pharmacology and Therapeutics, 1994, 249-254. Westenberg HGM, JA Den Boer. The neuropharmacology of anxiety: a review on the role of serotonin. In: JA Den Boer & JMA. Sitsen (Eds): Handbook of Depression and Anxiety, a Biological Approach ; Marcel Dekker Inc. New York, 1994, pp. 405-446. 1995 Den Boer JA, HGM Westenberg, HM van Praag (Eds). Advances in the Neurobiology of Schizophrenia. J. Wiley & Sons, Chichester, New York, Brisbane, Toronto, Singapore, 1995. Den Boer, JA, HGM Westenberg. Atypical antipsychotics in schizophrenia: recent andvances. In: Advances in the Neurobiology of Schizophrenia, JA Den Boer, HGM Westenberg & HM van Praag (Eds). J. Wiley & Sons, 1995, pp. 275-302. JA Den Boer, HGM Westenberg (Eds) Leerboek Angststoornissen; een Neurobiologische Benadering. Wetenschappelijke Uitgeverij De Tijdstroom, 1995. JA Den Boer en HGM Westenberg. De Locus Coeruleus hypothese van angststoornissen. In: JA Den Boer en HGM Westenberg (Red): Leerboek angststoornissen; een neurobiologische benadering. Wetenschappelijke Uitgeverij De Tijdstroom, 150-169, 1995 Westenberg HGM, JA Den Boer. De psychofarmacologie van angststoornissen: over synaptische transmissie en de invloed van psychofarmaca. In: JA den Boer & HGM Westenberg (Red.) Leerboek Angststoornissen, een Neurobiologische Benadering. Wetenschappelijke Uitgeverij De Tijdstroom 129-149, 1995. Westenberg HGM, JA Den Boer (1995). De serotonine hypothese van angststoornissen. In: JA Den Boer & HGM Westenberg (Red.): Leerboek angststoornissen; een neurobiologische benadering, Wetenschappelijke Uitgeverij 'de Tijdstroom', 171-183, 1995. JA Den Boer, BR Slaap. HGM Westenberg, Farmacotherapie van paniek en gegeneraliseerde angststoornis; huidige inzichten. In: JA Den Boer en HGM Westenberg (Red): Leerboek Angststoornissen; een Neurobiologische Benadering. Wetenschappelijke Uitgeverij De Tijdstroom, 234-266, 1995 Van Megen HJGM, HGM Westenberg, JA Den Boer. De rol van cholecystokinine bij de pathogenese van paniekstoornis. In: JA Den Boer, HGM Westenberg (Red.) Leerboek angststoornissen, een neurobiologische benadering. Wetenschappelijke Uitgeverij de Tijdstoorm, 185-198, 1995. De Leeuw AS, Den Boer JA, Westenberg HGM. Pathogenese van de obsessieve-compulsieve stoornis. In: JA Den Boer, HGM Westenberg (Red.) Leerboek angststoornissen, een neurobiologische benadering. Wetenschappelijke Uitgeverij de Tijdstoorm, 217-233, 1995.
Van Vliet, IM, JA Den Boer. Paniekstoornis met agorafobie en andere angststoornissen. In: 'Bijblijven'; Psychiatrie, deel I, Bohn, Stafleu & van Loghum, 20-29, 1995. Van Vliet IM, Den Boer JA, Westenberg HGM. De sociale fobie. Klinische, neurobiologische en farmacotherapeutische aspecten. In: JA Den Boer en HGM Westenberg (Red): Leerboek Angststoornissen; een Neurobiologische Benadering. Wetenschappelijke Uitgeverij De Tijdstroom, 284-302, 1995 Den Boer JA, AS de Leeuw, W Haayman, HGM Westenberg. Farmacotherapie van obsessief compulsieve stoornis. In: Leerboek Angststoornissen; een neurobiolgische benadering. Uitgeverij de Tijdstroom, 217-230, 1995. Den Boer JA. Janet en Morel in het licht van huidige opvattingen met betrekking tot diagnostiek en therapie van angststoornissen. In: EJ Brand (Ed.): Angst en Paniekstoornissen. Uitgeverij Wrede Veldt pp. 155-176, 1995. Den Boer JA. Farmacotherapie versus psychotherapie bij de behandeling van depressieve syndromen. In: O. Marx (Red.): Praten en Pillen', van Gorcum, 1995, 30-36. 1996 Den Boer, JA, RJ van den Bosch (Eds). Leerboek Schizofrenie; een Neurobiologische Benadering. Wetenschappelijke uitgeverij De Tijdstroom, Utrecht, 1996. Den Boer JA, JW Louwerens, BA Ellenbroek, Nieuwe ontwikkelingen op het gebied van atypische antipsychotica. In: Leerboek Schizofrenie, een neurobiologische benadering (JA Den Boer en RJ van den Bosch, Red.), 1996, 287-310. Louwerens JW, JA Den Boer. Farmacotherapie van schizofrenie. In: Leerboek schizofrenie, een neurobiologische benadering (JA Den Boer & RJ van den Bosch Eds.), 1996: 261-286. Westenberg HGM, JA Den Boer. De neurochemische basis voor psychofarmaca. In: Leerboek Schizofrenie, een neurobiologische benadering. (JA Den Boer & RJ van den Bosch Red.). Uitgeverij De Tijdstroom, 1996, 109-127. Den Boer JA, RJ van den Bosch. Epiloog. In: JA Den Boer & RJ van den Bosch (Eds.): Leerboek schizofrenie: een neurobiologische benadering. Uitgeverij De Tijdstroom, 1996, 312-315. Den Boer JA, Westenberg, HGM. Involvement of serotonin receptor sybtypes in panic disorder; a critical appraisal of the evidence In: HGM Westenberg, JA Den Boer, L Murphy, (Eds). Advances in the neurobiology of anxiety disorders. Wiley & Sons, Chichester 1996, pp. 139-172. Westenberg HGM, JA Den Boer, DL Murphy (Eds). Advances in the Neurobiology of Anxiety Disorders. (Series Clinical and neurobiological advances in Psychiatry, Vol. 2), Wiley & Sons, Chichester, 1996. Van Megen HJGM, HGM Westenberg, JA Den Boer, RS Kahn. Cholecystokinin in panic disorder. In: Westenberg HGM, JA Den Boer, DL Murphy (Eds). Advances in the Neurobiology of Anxiety Disorders. Wiley & Sons, Chichester, 1996, pp. 197-227. Den Boer JA, IM van Vliet, HGM Westenberg. Advances in the Psychopharmacology of Social Phobia, In: HGM Westenberg, JA Den Boer, H Murphy (Eds): Advances in the Neuro-biology of Anxiety Disorders. Wiley & Sons, Chichester, 1996, 401-418. 1997
Den Boer JA (Ed). Clinical Management of Anxiety: Theory and Practical Applications, Marcel Dekker Inc., New York/Basel/Hong Kong, 1997.(ISBN 0-8247-9777-9, 432 pp) Westenberg HGM, Den Boer JA. Neurobiology and the treatment of panic disorder. In: JA Den Boer (Ed.): Clinical Management of Anxiety; Theory and Practical Applications. Marcel Dekker Inc., New York/Basel/Hong Kong, 1997, 231-247. Den Boer JA, Westenberg HGM (Eds). Focus on Obsessive-Compulsive Spectrum Disorders. SynThesis, Amsterdam, 1997 (210 pp) Den Boer JA, Westenberg HGM, Challenge studies in obsessive-compulsive disorder. In: Den Boer JA, Westenberg HGM (Eds), Focus on Obsessive-Compulsive Spectrum Disorders, Syn-Thesis, Amsterdam, 1997, 123-134. Den Boer JA. Het buigzame brein. Over hersenen en geest, neuraal darwinisme en psychiatrie. Rede uitgesproken bij de aanvaarding van het ambt van hoogleraar in de Biologische Psychiatrie, Rijksuniversiteit Groningen. ISBN 90 367 07781. Van Megen HJGM, IM Van Vliet, HGM Westenberg, JA Den Boer. Anxiolytics as antidepressants. In: A Honig, M Ansseau, HM Van Praag (Eds): Depression: neurobiological, psychopathological and therapeutic advances. Wiley & Sons, Chichester, 1997, pp. 427-444. ISBN 0-471-96849 1998 Den Boer JA, Slaap BR, Bosker FJ. Biological aspects of anxiety disorders and depression. In: Montgomery SA, Den Boer JA (Eds), SSRIs in depression and anxiety, John Wiley & Sons, Chichester, 1998, 23-80. ISBN 0-471-97877-9. Montgomery SA, Den Boer JA (eds.). SSRIs in depression and anxiety. (Perspectives in Psychiatry, volume 7). John Wiley & Sons, Chichester, U.K., 1998, (pp 194). ISBN 0-471-97877-9. Den Boer JA. Farmacotherapie bij de paniekstoornis. In: Flemming, Westphal, Da Costa, Beard, Angst- en paniekstoornissen deel II De teksten, Candide/Wrede Veldt, Amsterdam, 1998, 223-237. ISBN 90 -75483-15-5. 1999 Van Vliet IM, Den Boer JA. Angststoornissen. In: Farmacotherapie in de psychiatrie, Kahn RS, Zitman FG (eds), Elsevier/Bunge, Maarssen, 1999, 51-63. ISBN 90-352-20536. Den Boer JA, Ormel J, Van Praag HM, Westenberg HGN, D'haenen H. (Red). Handboek stemmingsstoornissen. Elsevier/De Tijdstroom, Maarssen, 1999, 392 pp. ISBN 90-352-2065-X. Van Vliet IM, Den Boer JA, Van Megen HJGM, Bosker F, Slaap BR, Westenberg HGM. Anxiolytica als antidepressiva. In: Den Boer JA, Ormel J, Van Praag HM, Westenberg HGN, D'haenen H. (Red). Handboek stemmingsstoornissen. Elsevier/De Tijdstroom, Maarssen, 1999, 222-231. Den Boer JA. Increasing our understanding of the working mechanism of antidepressants. In: Depressive Disorders, WPA Series, Evidenc and experience in Psychiatry, Maj M and Sartorius N (eds). John Wiley & Sons, Ltd. Chichester, UK, 1999. Westenberg HGM, Den Boer JA. (eds.) Focus on psychiatry. Social anxiety disorder. Syn-Thesis publishers, Amsterdam, 1999, 222 pp, ISBN 90 73637 45 7.
Van Vliet IM, Den Boer JA. Angststoornissen. In: Farmacotherapie in de psychiatrie. Kahn RS en Zitma FG (red.). Elsevier/Bunge, Maarssen, 1999, pp 51-63. ISBN: 90-352-2053-6. 2000 Tulner DM, Den Boer JA. Heart disease and cognitive/neuropsychiatric disorders. In: The nervous system and the heart. G.J. ter Horst (ed). Human Press Inc., Totowa, USA, 2000, pp. 491-546. ISBN 0-89603-693-6. Den Boer JA, Korf J. Dopamine receptor subtypes and schizophrenia: a clinical perspective. In Ellenbroek BA en Cools AR (eds) Atypical antipsychotics. Birkhäuser Verlag AG, Basel, 2000, pp. 163-191. ISBN 3-7643-5948-X. Den Boer JA. Treatment and Neurobiology of Obsessive Compulsive Disorder. Commentary included in the volume on obsessive-compulsive disorder of the WPA Series “Evidence and Experience in Psychiatry”, Maj M, Sartorius N, Okasha A, Zohar J (eds). John Wiley and Sons, U.K., volume 4, 2000. Den Boer JA, Van Vliet IM. Farmacotherapie van angststoornissen. In: R Kahn, F Zitman (eds) Farmacotherapie in de Psychiatrie. Bunge, Utrecht, 2000. 2001 Montgomery SA, Den Boer JA (eds.). SSRIs in depression and anxiety, revised. (Perspectives in Psychiatry, volume 8). John Wiley & Sons, Chichester, U.K., 2001, (pp 216). ISBN 0-470-84136-2. Den Boer JA, Slaap BR, Bosker FJ. Biological aspects of anxiety disorders and depression.In: Montgomery SA, Den Boer JA (Eds), SSRIs in depression and anxiety, John Wiley & Sons, Chichester, 2001, 25-85. ISBN 0-470-84136-2. Den Boer JA, Westenberg HGM (eds). Antidepressants: Selectivity or multiplicity. In: Focus on Psychiatry book series, Syn-Thesis publicers, Amsterdam, 2001. ISBN 90-73637-52-X. Westenberg HGM, Den Boer JA. Pharmacology of antidepressants: selectivity of multiplicity? In: Den Boer JA, Westenberg HGM (Eds.), Antidepressants: Selectivity or multiplicity, pp. 31-42, SynThesis publicers, Amsterdam, 2001. Cremers TIFH, Bosker FJ, Westenberg HGM, Den Boer JA. Antidepressants: selectivity or multiplicity? In: Den Boer JA, Westenberg HGM (Eds.), Antidepressants: Selectivity or multiplicity, pp. 61-84, Syn-Thesis publicers, Amsterdam, 2001. 2002 D’haenen HAH, Den Boer JA, Willner P (Eds). Biological Psychiatry (volume 1 and 2). John Wiley & Sons, Chichester, 2002. Den Boer JA, Slaap BR, Ter Horst GJ, Cremers TIFH, & Bosker FJ. Therapeutic armamentarium in anxiety disorders. D’Haenen, H, Den Boer JA, Willner, P (Eds.).In: Biological Psychiatry, pp. 10391062, John Wiley & Sons, Chichester, 2002. 2003 Kasper S, Den Boer JA, Sitsen JMA (eds). Handbook of Depression and Anxiety. Second edition, revised and expanded. New York, Marcel Dekker, Inc., 2003.
Trentani A, Kuipers S, Ter Horst GJ, Den Boer JA. Intracellular signaling transduction dysregulation in depression and possible future targets for antidepressant therapy: beyond the serotonin hypothesis. In: Handbook of Depression and Anxiety, pp. 349-385, Marcel Dekker, Inc., New York, 2003. Den Boer JA, Van Hout WJPJ, Nielen MMA, Ter Horst GJ. Neuropsychiatrie van paniekstoornis; een integratie van neurobiologische en psychologische modellen. Eling P, De Haan E, Hijman R & Schmand B (Eds.). In: Cognitieve neuropsychiatrie, pp. 138-181, Uitgeverij Boom, Amsterdam, 2003. Nielen MMA, Van Hout WJPJ, Den Boer JA. Cognitief neuropsychiatrisch onderzoek bij obsessiefcompulsieve stoornis. Eling P, De Haan E, Hijman R & Schmand B (Eds.). In: Cognitieve neuropsychiatrie, pp. 182-213, Uitgeverij Boom, Amsterdam, 2003. Den Boer JA. Neurofilosofie. Hersenen, bewustzijn en vrije wil. Uitgeverij Boom, Amsterdam, 2003.
